Breaking News

Financial Report: BASi

December 28, 2012

Restructuring charges impacts results


4Q Revenues: $6.5 million (-20%)

4Q Loss: $2.3 million (loss of $668,000 4Q11)

YTD Revenues: $28.2 million (-15%)

YTD Loss: $6.4 million (earnings were $543,000 YTD11)

Comments: Service revenue was down 17% in the quarter to $5.2 million. Product revenue was down 29% to $1.3 million. Restructuring charges were $2.5 million in the quarter and $3.2 million for the year. Revenue decline is attributed to the consolidation of the company's Oregon facility into its West Lafayette facility and the closure of its UK lab.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks